Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001437749-22-021929 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-06 | 2022-09-01 | BLFS | MOORE TIMOTHY L. | Dir | A - Grant | — | +7,589 | 7,589 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-01 | A | A | 7,589 | — | 7,589 | D | — | — | (F1) The restricted stock award was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and fully vests on the first anniversary of the grant date. |